Home » Abbott Offers Concessions in EU Review of Solvay Transaction
Abbott Offers Concessions in EU Review of Solvay Transaction
Abbott Laboratories offered concessions to the European Union in a bid to win approval for its $6.8 billion purchase of Solvay SA’s drug unit after
regulators had concerns about a diagnostic test.
DailyHerald
DailyHerald
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May